Birdwatch Note
2025-04-17 17:47:02 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
No, there is no evidence that dimethyl sulfoxide (DMSO) cures cancer. While some research suggests it may have anti-cancer effects, it has not been proven to be an effective treatment in humans, and there are potential risks associated with its use https://aacrjournals.org/cancerres/article/74/14/3913/592777/Say-No-to-DMSO-Dimethylsulfoxide-Inactivates https://www.mskcc.org/cancer-care/integrative-medicine/herbs/dimethylsulfoxide https://www.webmd.com/vitamins-and-supplements/dmso-uses-and-risks
Written by 2A6B630D0AEA2ACC36E2189A989B042C8F44788D5C6526EF4EAC8856A79A73D8
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1912728083229966348
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1912925785897279504
- noteId - 1912925785897279504
- participantId -
- noteAuthorParticipantId - 2A6B630D0AEA2ACC36E2189A989B042C8F44788D5C6526EF4EAC8856A79A73D8
- createdAtMillis - 1744912022457
- tweetId - 1912728083229966348
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- No, there is no evidence that dimethyl sulfoxide (DMSO) cures cancer. While some research suggests it may have anti-cancer effects, it has not been proven to be an effective treatment in humans, and there are potential risks associated with its use https://aacrjournals.org/cancerres/article/74/14/3913/592777/Say-No-to-DMSO-Dimethylsulfoxide-Inactivates https://www.mskcc.org/cancer-care/integrative-medicine/herbs/dimethylsulfoxide https://www.webmd.com/vitamins-and-supplements/dmso-uses-and-risks
Note Ratings
| rated at | rated by | |
| 2025-04-25 18:46:35 -0500 | Rating Details | |
| 2025-04-23 07:19:25 -0500 | Rating Details | |
| 2025-04-18 00:18:06 -0500 | Rating Details | |
| 2025-04-17 22:40:50 -0500 | Rating Details | |
| 2025-04-17 19:44:39 -0500 | Rating Details | |
| 2025-04-17 12:59:37 -0500 | Rating Details | |
| 2025-04-30 12:43:46 -0500 | Rating Details | |
| 2025-04-22 06:36:33 -0500 | Rating Details | |
| 2025-04-21 14:09:42 -0500 | Rating Details | |
| 2025-04-21 12:19:22 -0500 | Rating Details | |
| 2025-04-18 03:19:27 -0500 | Rating Details | |
| 2025-04-17 21:53:20 -0500 | Rating Details | |
| 2025-04-17 21:50:07 -0500 | Rating Details | |
| 2025-04-17 21:32:41 -0500 | Rating Details | |
| 2025-04-17 19:43:48 -0500 | Rating Details | |
| 2025-04-17 19:37:35 -0500 | Rating Details | |
| 2025-04-17 19:12:22 -0500 | Rating Details | |
| 2025-04-17 16:41:28 -0500 | Rating Details | |
| 2025-04-17 15:08:26 -0500 | Rating Details | |
| 2025-04-17 14:36:53 -0500 | Rating Details | |
| 2025-04-17 14:23:46 -0500 | Rating Details | |
| 2025-04-17 13:33:05 -0500 | Rating Details | |
| 2025-04-17 13:24:12 -0500 | Rating Details | |
| 2025-04-27 21:57:50 -0500 | Rating Details | |
| 2025-04-26 21:26:17 -0500 | Rating Details | |
| 2025-04-23 10:42:16 -0500 | Rating Details | |
| 2025-04-18 19:10:06 -0500 | Rating Details | |
| 2025-04-18 01:27:27 -0500 | Rating Details | |
| 2025-04-18 00:43:17 -0500 | Rating Details | |
| 2025-04-17 23:22:20 -0500 | Rating Details | |
| 2025-04-17 22:34:05 -0500 | Rating Details | |
| 2025-04-17 18:35:26 -0500 | Rating Details | |
| 2025-04-17 15:38:50 -0500 | Rating Details | |
| 2025-04-17 14:52:07 -0500 | Rating Details | |
| 2025-04-17 14:23:20 -0500 | Rating Details | |
| 2025-04-17 14:15:55 -0500 | Rating Details | |
| 2025-04-17 13:41:34 -0500 | Rating Details | |
| 2025-04-17 13:06:17 -0500 | Rating Details | |
| 2025-04-17 12:51:55 -0500 | Rating Details | |
| 2025-04-27 08:16:49 -0500 | Rating Details | |
| 2025-04-26 22:38:08 -0500 | Rating Details | |
| 2025-04-26 16:52:51 -0500 | Rating Details | |
| 2025-04-20 01:12:23 -0500 | Rating Details | |
| 2025-04-18 22:29:51 -0500 | Rating Details | |
| 2025-04-17 19:28:54 -0500 | Rating Details | |
| 2025-04-17 13:27:27 -0500 | Rating Details | |
| 2025-04-17 13:09:35 -0500 | Rating Details | |
| 2025-04-17 12:57:04 -0500 | Rating Details | |
| 2025-04-23 16:14:14 -0500 | Rating Details | |
| 2025-04-23 07:07:25 -0500 | Rating Details | |
| 2025-04-20 23:24:01 -0500 | Rating Details | |
| 2025-04-18 19:13:36 -0500 | Rating Details | |
| 2025-04-18 08:01:12 -0500 | Rating Details | |
| 2025-04-18 06:49:15 -0500 | Rating Details | |
| 2025-04-18 06:35:33 -0500 | Rating Details | |
| 2025-04-18 03:39:55 -0500 | Rating Details | |
| 2025-04-17 23:03:21 -0500 | Rating Details | |
| 2025-04-17 19:38:06 -0500 | Rating Details | |
| 2025-04-17 19:02:22 -0500 | Rating Details | |
| 2025-04-17 18:59:53 -0500 | Rating Details | |
| 2025-04-17 18:55:47 -0500 | Rating Details | |
| 2025-04-17 14:36:17 -0500 | Rating Details | |
| 2025-05-15 04:48:10 -0500 | Rating Details | |
| 2025-04-27 10:39:09 -0500 | Rating Details | |
| 2025-04-23 08:38:34 -0500 | Rating Details | |
| 2025-04-18 08:28:28 -0500 | Rating Details | |
| 2025-04-18 07:56:28 -0500 | Rating Details | |
| 2025-04-18 04:59:02 -0500 | Rating Details | |
| 2025-04-17 23:13:10 -0500 | Rating Details | |
| 2025-04-17 22:28:46 -0500 | Rating Details | |
| 2025-04-17 22:11:00 -0500 | Rating Details | |
| 2025-04-17 22:03:50 -0500 | Rating Details | |
| 2025-04-17 16:11:28 -0500 | Rating Details | |
| 2025-04-17 13:59:04 -0500 | Rating Details | |
| 2025-04-17 13:09:54 -0500 | Rating Details | |
| 2025-04-17 13:07:22 -0500 | Rating Details | |
| 2025-04-17 12:52:56 -0500 | Rating Details | |
| 2025-04-30 15:16:21 -0500 | Rating Details | |
| 2025-04-30 10:19:04 -0500 | Rating Details | |
| 2025-04-23 17:31:59 -0500 | Rating Details | |
| 2025-04-20 11:09:24 -0500 | Rating Details | |
| 2025-04-17 21:37:23 -0500 | Rating Details | |
| 2025-04-17 19:45:27 -0500 | Rating Details | |
| 2025-04-17 19:05:16 -0500 | Rating Details | |
| 2025-04-17 13:53:36 -0500 | Rating Details | |
| 2025-04-17 13:28:09 -0500 | Rating Details | |
| 2025-04-17 12:50:10 -0500 | Rating Details | |
| 2025-04-17 12:48:08 -0500 | Rating Details | |
| 2025-05-02 02:03:23 -0500 | Rating Details | |
| 2025-04-23 17:27:39 -0500 | Rating Details | |
| 2025-04-23 07:07:53 -0500 | Rating Details | |
| 2025-04-21 02:59:43 -0500 | Rating Details | |
| 2025-04-19 02:32:01 -0500 | Rating Details | |
| 2025-04-18 15:29:15 -0500 | Rating Details | |
| 2025-04-18 10:48:46 -0500 | Rating Details | |
| 2025-04-17 22:25:14 -0500 | Rating Details | |
| 2025-04-17 20:17:52 -0500 | Rating Details | |
| 2025-04-17 20:14:18 -0500 | Rating Details | |
| 2025-04-17 16:06:20 -0500 | Rating Details | |
| 2025-04-17 15:41:54 -0500 | Rating Details | |
| 2025-04-17 14:59:59 -0500 | Rating Details | |
| 2025-04-17 14:12:42 -0500 | Rating Details | |
| 2025-04-17 13:57:23 -0500 | Rating Details | |
| 2025-04-17 13:23:11 -0500 | Rating Details | |
| 2025-04-17 13:09:44 -0500 | Rating Details | |
| 2025-04-17 13:02:00 -0500 | Rating Details | |
| 2025-04-17 12:50:40 -0500 | Rating Details | |
| 2025-04-17 12:49:26 -0500 | Rating Details | |
| 2025-04-30 10:39:28 -0500 | Rating Details | |
| 2025-04-25 18:37:05 -0500 | Rating Details | |
| 2025-04-23 08:15:09 -0500 | Rating Details | |
| 2025-04-21 07:30:09 -0500 | Rating Details | |
| 2025-04-18 21:49:38 -0500 | Rating Details | |
| 2025-04-18 07:55:13 -0500 | Rating Details | |
| 2025-04-18 03:40:26 -0500 | Rating Details | |
| 2025-04-17 23:25:16 -0500 | Rating Details | |
| 2025-04-17 22:50:07 -0500 | Rating Details | |
| 2025-04-17 22:04:28 -0500 | Rating Details | |
| 2025-04-17 21:34:20 -0500 | Rating Details | |
| 2025-04-17 20:38:08 -0500 | Rating Details | |
| 2025-04-17 18:55:26 -0500 | Rating Details | |
| 2025-04-17 14:55:17 -0500 | Rating Details | |
| 2025-04-17 14:21:34 -0500 | Rating Details | |
| 2025-04-17 13:56:43 -0500 | Rating Details | |
| 2025-04-17 13:53:29 -0500 | Rating Details | |
| 2025-04-17 13:47:25 -0500 | Rating Details | |
| 2025-04-17 13:44:43 -0500 | Rating Details | |
| 2025-04-17 13:08:20 -0500 | Rating Details | |
| 2025-04-30 15:53:09 -0500 | Rating Details | |
| 2025-04-19 15:19:53 -0500 | Rating Details | |
| 2025-04-18 08:20:17 -0500 | Rating Details | |
| 2025-04-17 22:23:39 -0500 | Rating Details | |
| 2025-04-17 18:54:55 -0500 | Rating Details | |
| 2025-04-17 17:28:48 -0500 | Rating Details | |
| 2025-04-17 15:30:43 -0500 | Rating Details | |
| 2025-04-17 15:14:43 -0500 | Rating Details | |
| 2025-04-17 15:01:42 -0500 | Rating Details | |
| 2025-04-17 14:25:01 -0500 | Rating Details | |
| 2025-04-17 14:20:20 -0500 | Rating Details | |
| 2025-04-17 14:06:09 -0500 | Rating Details | |
| 2025-04-17 13:54:09 -0500 | Rating Details | |
| 2025-04-17 13:48:51 -0500 | Rating Details | |
| 2025-04-17 13:48:09 -0500 | Rating Details | |
| 2025-04-17 13:43:46 -0500 | Rating Details | |
| 2025-04-17 13:17:27 -0500 | Rating Details | |
| 2025-04-17 13:05:55 -0500 | Rating Details | |
| 2025-04-17 12:56:01 -0500 | Rating Details | |
| 2025-04-17 12:50:39 -0500 | Rating Details | |
| 2025-04-17 23:02:13 -0500 | Rating Details | |
| 2025-04-17 12:53:52 -0500 | Rating Details | |
| 2025-04-24 15:40:40 -0500 | Rating Details | |
| 2025-04-21 01:29:45 -0500 | Rating Details | |
| 2025-04-17 14:01:33 -0500 | Rating Details | |
| 2025-04-17 12:54:49 -0500 | Rating Details | |
| 2025-04-17 12:49:57 -0500 | Rating Details | |
| 2025-04-23 19:11:03 -0500 | Rating Details | |
| 2025-04-17 19:24:52 -0500 | Rating Details | |
| 2025-04-17 13:31:09 -0500 | Rating Details | |
| 2025-04-17 16:37:26 -0500 | Rating Details | |
| 2025-04-23 01:26:07 -0500 | Rating Details | |
| 2025-04-21 08:54:49 -0500 | Rating Details | |
| 2025-04-21 08:54:46 -0500 | Rating Details | |
| 2025-04-18 00:19:27 -0500 | Rating Details | |
| 2025-04-17 14:02:18 -0500 | Rating Details | |
| 2025-04-17 14:01:00 -0500 | Rating Details | |
| 2025-04-27 08:59:41 -0500 | Rating Details | |
| 2025-04-17 12:56:37 -0500 | Rating Details | |
| 2025-04-17 12:54:30 -0500 | Rating Details | |
| 2025-04-17 13:10:34 -0500 | Rating Details | |
| 2025-05-12 07:22:31 -0500 | Rating Details | |
| 2025-04-18 09:52:11 -0500 | Rating Details | |
| 2025-04-18 03:52:02 -0500 | Rating Details | |
| 2025-04-17 17:47:10 -0500 | Rating Details | |
| 2025-04-17 16:11:58 -0500 | Rating Details | |
| 2025-04-17 14:30:50 -0500 | Rating Details | |
| 2025-04-17 12:48:37 -0500 | Rating Details | |
| 2025-04-18 19:21:53 -0500 | Rating Details | |
| 2025-04-17 21:50:33 -0500 | Rating Details | |
| 2025-04-17 13:54:27 -0500 | Rating Details | |
| 2025-04-17 13:46:44 -0500 | Rating Details | |
| 2025-04-17 22:36:37 -0500 | Rating Details | |
| 2025-04-17 17:49:24 -0500 | Rating Details | |
| 2025-04-17 13:43:56 -0500 | Rating Details |